title: Soybean isoflavone genistein regulates apoptosis through NF-κB dependent and independent pathways.
abstract: Cyclooxygenase-2 (COX-2), the key enzyme of the conversion of arachidonic acid to prostaglandins is an important regulator of inflammation and perhaps apoptosis. Genistein is an active component of legumes and other related food associated with prevention of degenerative diseases possibly through modulating certain signaling pathways. It was investigated whether the induction of apoptosis with genistein was carried out via COX-2 suppression through the regulation of NF-κB. The cox-2 positive and negative cells were used to compare the effect of genistein on the modulation of NF-κB in COX-2 expressed or non-expressed genotypic systems. Suppression of COX-2 as well as decreasing NF-κB DNA binding activity was accompanied with the induction of apoptosis in genistein-treated COX-2 expressed cells. However, in cox-2 negative cells, apoptosis occurred without any involvement of NF-κB with genistein treatement. Genistein induced apoptosis through the generation of reactive oxygen species (ROS) both of cox-2 positive and negative cells. These results suggested that genistein is capable of exihibiting NF-κB-dependent and NF-κB-independent apoptotic control via ROS generation depending on genetic cell types.
authors: Department of Food and Nutrition, Hannam University Daedeok Valley Campus, 461-6 Jeonmin-dong, Yusung-gu, Daejeon 305-811, South Korea.
authors: Yun-Kyoung
authors: YK
authors: Lee
authors: Ock Jin
authors: OJ
authors: Park
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D015153:Blotting, Western; D000068579:Celecoxib; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism*; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D004797:Enzyme-Linked Immunosorbent Assay; D019833:Genistein / Q000302:isolation & purification / Q000494:pharmacology*; D020287:In Situ Nick-End Labeling; D016328:NF-kappa B / Q000378:metabolism*; D011720:Pyrazoles / Q000494:pharmacology; D017382:Reactive Oxygen Species / Q000378:metabolism; D013025:Glycine max / Q000737:chemistry*; D013449:Sulfonamides / Q000494:pharmacology
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016328:NF-kappa B; D011720:Pyrazoles; D017382:Reactive Oxygen Species; D013449:Sulfonamides; D019833:Genistein; D051546:Cyclooxygenase 2; D000068579:Celecoxib; D015232:Dinoprostone